Respiro Diagnostics
Develops breath-based diagnostic platform for lung cancer and respiratory diseases
£1MPre-Seed
Role not disclosedActivity from announced rounds
Develops breath-based diagnostic platform for lung cancer and respiratory diseases
Provides AI platform to detect, predict and prevent hospital-acquired infections for NHS and global hospitals